DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 3819-00-9, Quide, Psymod, Piperacetazinum, Pc-1421, 1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone

Molecular Formula

C₂₄H₃₀N₂O₂S

Molecular Weight

410.6 g/mol

InChI Key

BTFMCMVEUCGQDX-UHFFFAOYSA-N

FDA UNII

KL6248WNW4

1 2D Structure

Piperacetazine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone

2.1.2 InChI

InChI=1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3

2.1.3 InChI Key

BTFMCMVEUCGQDX-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO

2.2 Other Identifiers

2.2.1 UNII

KL6248WNW4

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 3819-00-9

2. Quide

3. Psymod

4. Piperacetazinum

5. Pc-1421

6. 1-[10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]phenothiazin-2-yl]ethanone

7. Sc 9794

8. Nsc-760067

9. 10-(3-(4-(2-hydroxyethyl)piperidino)propyl)phenothiazin-2-yl Methyl Ketone

10. Kl6248wnw4

11. Ethanone, 1-(10-(3-(4-(2-hydroxyethyl)-1-piperidinyl)propyl)-10h-phenothiazin-2-yl)-

12. Ncgc00016642-01

13. Cas-3819-00-9

14. Dsstox_cid_3481

15. Ketone, 10-(3-(4-(2-hydroxyethyl)piperidino)propyl)phenothiazin-2-yl Methyl

16. 1-(10-(3-(4-(2-hydroxyethyl)-1-piperidinyl)propyl)-10h-phenothiazin-2-yl)ethanone

17. Dsstox_rid_77047

18. Dsstox_gsid_23481

19. Piperacetazina [inn-spanish]

20. Piperacetazina

21. Piperazetazina

22. Piperazetazina [dcit]

23. Ethanone, 1-[10-[3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl]-10h-phenothiazin-2-yl]-

24. Piperacetazinum [inn-latin]

25. Einecs 223-312-0

26. Unii-kl6248wnw4

27. Piperacetazine [usan:usp:inn]

28. 1-(10-{3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl}-10h-phenothiazin-2-yl)ethanone

29. Quide (tn)

30. Prestwick0_001048

31. Prestwick1_001048

32. Prestwick2_001048

33. Prestwick3_001048

34. 2-acetyl-10-(3-(4-(beta-hydroxyethyl)piperidino)propyl)phenothiazine

35. Piperacetazine [mi]

36. Chembl1584

37. Piperacetazine (usan/inn)

38. Piperacetazine [inn]

39. Bspbio_000976

40. Piperacetazine [usan]

41. Mls002154124

42. Piperacetazine [vandf]

43. Schembl148569

44. Spbio_002908

45. Piperacetazine [mart.]

46. Piperacetazine(250mg)

47. Bpbio1_001074

48. Piperacetazine [who-dd]

49. Dtxsid7023481

50. Chebi:92293

51. Hms1571a18

52. Hms2098a18

53. Hms2230g17

54. Hms3369h17

55. Hms3715a18

56. Pharmakon1600-01503874

57. Zinc538186

58. Piperacetazine [green Book]

59. Hy-b1152

60. Piperacetazine [orange Book]

61. Tox21_110540

62. Nsc760067

63. Akos030526141

64. Tox21_110540_1

65. Ccg-213229

66. Cs-4756

67. Nsc 760067

68. Ncgc00016642-02

69. Ncgc00016642-04

70. Ncgc00179353-01

71. As-56571

72. Smr001233431

73. Ab00514021

74. D02679

75. D85498

76. Ab00514021_06

77. 819p009

78. Sr-01000841199

79. Q3905512

80. Sr-01000841199-2

81. Z2065671295

82. 2-acetyl-10-(3-(4-(.beta.-hydroxyethyl)piperidino)propyl)phenothiazine

83. 1-(10-(3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl)-10h-phenothiazin-2-yl)ethanone #

84. 1-(10-{3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl}-10h-phenothiazin-2-yl)ethanone

85. 1-[10-[3-[4-(2-hydroxyethyl)-1-piperidinyl]propyl]-2-phenothiazinyl]ethanone

86. 1-(10-{3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl}-10h-phenothiazin-2-yl)ethan-1-one

2.4 Create Date

2005-03-27

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₃₀N₂O₂S
Molecular Weight	410.6 g/mol
XLogP3	4
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	7
Exact Mass	410.20279938 g/mol
Monoisotopic Mass	410.20279938 g/mol
Topological Polar Surface Area	69.1 Å²
Heavy Atom Count	29
Formal Charge	0
Complexity	537
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1